Background: We aimed to assess the ability of comprehensive complication index (CCI) and Clavien‐Dindo complication (CDC) scale to predict excessive length of hospital stay (e‐LOS) in patients undergoing liver resection for hepatocellular carcinoma. Methods: Patients were identified from an Italian multi‐institutional database and randomly selected to be included in either a derivation or validation set. Multivariate logistic regression models and ROC curve analysis including either CCI or CDC as predictors of e‐LOS were fitted to compare predictive performance. E‐LOS was defined as a LOS longer than the 75th percentile among patients with at least one complication. Results: A total of 2669 patients were analyzed (1345 for derivation and 1324 for validation). The odds ratio (OR) was 5.590 (95%CI 4.201; 7.438) for CCI and 5.507 (4.152; 7.304) for CDC. The AUC was 0.964 for CCI and 0.893 for CDC in the derivation set and 0.962 vs. 0.890 in the validation set, respectively. In patients with at least two complications, the OR was 2.793 (1.896; 4.115) for CCI and 2.439 (1.666; 3.570) for CDC with an AUC of 0.850 and 0.673, respectively in the derivation cohort. The AUC was 0.806 for CCI and 0.658 for CDC in the validation set. Conclusions: When reporting postoperative morbidity in liver surgery, CCI is a preferable scale.

Background: We aimed to assess the ability of comprehensive complication index (CCI) and Clavien-Dindo complication (CDC) scale to predict excessive length of hospital stay (e-LOS) in patients undergoing liver resection for hepatocellular carcinoma. Methods: Patients were identified from an Italian multi-institutional database and randomly selected to be included in either a derivation or validation set. Multivariate logistic regression models and ROC curve analysis including either CCI or CDC as predictors of e-LOS were fitted to compare predictive performance. E-LOS was defined as a LOS longer than the 75th percentile among patients with at least one complication. Results: A total of 2669 patients were analyzed (1345 for derivation and 1324 for validation). The odds ratio (OR) was 5.590 (95%CI 4.201; 7.438) for CCI and 5.507 (4.152; 7.304) for CDC. The AUC was 0.964 for CCI and 0.893 for CDC in the derivation set and 0.962 vs. 0.890 in the validation set, respectively. In patients with at least two complications, the OR was 2.793 (1.896; 4.115) for CCI and 2.439 (1.666; 3.570) for CDC with an AUC of 0.850 and 0.673, respectively in the derivation cohort. The AUC was 0.806 for CCI and 0.658 for CDC in the validation set. Conclusions: When reporting postoperative morbidity in liver surgery, CCI is a preferable scale.

Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma / Giani, A.; Cipriani, F.; Famularo, S.; Donadon, M.; Bernasconi, D. P.; Ardito, F.; Fazio, F.; Nicolini, D.; Perri, P.; Giuffrida, M.; Pontarolo, N.; Zanello, M.; Lai, Q.; Conci, S.; Molfino, S.; Germani, P.; Pinotti, E.; Romano, M.; La Barba, G.; Ferrari, C.; Patauner, S.; Manzoni, A.; Sciannamea, I.; Fumagalli, L.; Troci, A.; Ferraro, V.; Floridi, A.; Memeo, R.; Crespi, M.; Chiarelli, M.; Antonucci, A.; Zimmitti, G.; Frena, A.; Percivale, A.; Ercolani, G.; Zanus, G.; Zago, M.; Tarchi, P.; Baiocchi, G. L.; Ruzzenente, A.; Rossi, M.; Jovine, E.; Maestri, M.; Valle, R. D.; Grazi, G. L.; Vivarelli, M.; Ferrero, A.; Giuliante, F.; Torzilli, G.; Aldrighetti, L.; Gianotti, L.; Romano, F.; Ciulli, C.; Braga, M.; Ratti, F.; Costa, G.; Razionale, F.; Russolillo, N.; Marinelli, L.; De Peppo, V.; Cremaschi, E.; Calabrese, F.; Laureiro, Z. L.; Lazzari, G.; Cosola, D.; Montuori, M.; Salvador, L.; Cucchetti, A.; Franceschi, A.; Ciola, M.; Sega, V.; Calcagno, P.; Pennacchi, L.; Tedeschi, M.. - In: CANCERS. - ISSN 2072-6694. - 12:12(2020), pp. 1-15. [10.3390/cancers12123868]

Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma

Ardito F.;Nicolini D.;Giuffrida M.;Lai Q.;Molfino S.;Ferraro V.;Zago M.;Rossi M.;Grazi G. L.;Vivarelli M.;Braga M.;De Peppo V.;Laureiro Z. L.;Lazzari G.;Montuori M.;Calcagno P.;Pennacchi L.;Tedeschi M.
2020

Abstract

Background: We aimed to assess the ability of comprehensive complication index (CCI) and Clavien‐Dindo complication (CDC) scale to predict excessive length of hospital stay (e‐LOS) in patients undergoing liver resection for hepatocellular carcinoma. Methods: Patients were identified from an Italian multi‐institutional database and randomly selected to be included in either a derivation or validation set. Multivariate logistic regression models and ROC curve analysis including either CCI or CDC as predictors of e‐LOS were fitted to compare predictive performance. E‐LOS was defined as a LOS longer than the 75th percentile among patients with at least one complication. Results: A total of 2669 patients were analyzed (1345 for derivation and 1324 for validation). The odds ratio (OR) was 5.590 (95%CI 4.201; 7.438) for CCI and 5.507 (4.152; 7.304) for CDC. The AUC was 0.964 for CCI and 0.893 for CDC in the derivation set and 0.962 vs. 0.890 in the validation set, respectively. In patients with at least two complications, the OR was 2.793 (1.896; 4.115) for CCI and 2.439 (1.666; 3.570) for CDC with an AUC of 0.850 and 0.673, respectively in the derivation cohort. The AUC was 0.806 for CCI and 0.658 for CDC in the validation set. Conclusions: When reporting postoperative morbidity in liver surgery, CCI is a preferable scale.
2020
Background: We aimed to assess the ability of comprehensive complication index (CCI) and Clavien-Dindo complication (CDC) scale to predict excessive length of hospital stay (e-LOS) in patients undergoing liver resection for hepatocellular carcinoma. Methods: Patients were identified from an Italian multi-institutional database and randomly selected to be included in either a derivation or validation set. Multivariate logistic regression models and ROC curve analysis including either CCI or CDC as predictors of e-LOS were fitted to compare predictive performance. E-LOS was defined as a LOS longer than the 75th percentile among patients with at least one complication. Results: A total of 2669 patients were analyzed (1345 for derivation and 1324 for validation). The odds ratio (OR) was 5.590 (95%CI 4.201; 7.438) for CCI and 5.507 (4.152; 7.304) for CDC. The AUC was 0.964 for CCI and 0.893 for CDC in the derivation set and 0.962 vs. 0.890 in the validation set, respectively. In patients with at least two complications, the OR was 2.793 (1.896; 4.115) for CCI and 2.439 (1.666; 3.570) for CDC with an AUC of 0.850 and 0.673, respectively in the derivation cohort. The AUC was 0.806 for CCI and 0.658 for CDC in the validation set. Conclusions: When reporting postoperative morbidity in liver surgery, CCI is a preferable scale.
Clavien‐Dindo classification; Comprehensive complication index; Hepatocellular carcinoma; Length of stay; Liver surgery; Morbidity; Performance
01 Pubblicazione su rivista::01a Articolo in rivista
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma / Giani, A.; Cipriani, F.; Famularo, S.; Donadon, M.; Bernasconi, D. P.; Ardito, F.; Fazio, F.; Nicolini, D.; Perri, P.; Giuffrida, M.; Pontarolo, N.; Zanello, M.; Lai, Q.; Conci, S.; Molfino, S.; Germani, P.; Pinotti, E.; Romano, M.; La Barba, G.; Ferrari, C.; Patauner, S.; Manzoni, A.; Sciannamea, I.; Fumagalli, L.; Troci, A.; Ferraro, V.; Floridi, A.; Memeo, R.; Crespi, M.; Chiarelli, M.; Antonucci, A.; Zimmitti, G.; Frena, A.; Percivale, A.; Ercolani, G.; Zanus, G.; Zago, M.; Tarchi, P.; Baiocchi, G. L.; Ruzzenente, A.; Rossi, M.; Jovine, E.; Maestri, M.; Valle, R. D.; Grazi, G. L.; Vivarelli, M.; Ferrero, A.; Giuliante, F.; Torzilli, G.; Aldrighetti, L.; Gianotti, L.; Romano, F.; Ciulli, C.; Braga, M.; Ratti, F.; Costa, G.; Razionale, F.; Russolillo, N.; Marinelli, L.; De Peppo, V.; Cremaschi, E.; Calabrese, F.; Laureiro, Z. L.; Lazzari, G.; Cosola, D.; Montuori, M.; Salvador, L.; Cucchetti, A.; Franceschi, A.; Ciola, M.; Sega, V.; Calcagno, P.; Pennacchi, L.; Tedeschi, M.. - In: CANCERS. - ISSN 2072-6694. - 12:12(2020), pp. 1-15. [10.3390/cancers12123868]
File allegati a questo prodotto
File Dimensione Formato  
cancers-12-03868.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 2.25 MB
Formato Adobe PDF
2.25 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1498971
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 12
social impact